Indisulam

CAS No. 165668-41-7

Indisulam ( E 7070;E7070 )

Catalog No. M12528 CAS No. 165668-41-7

Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 55 In Stock
10MG 77 In Stock
25MG 125 In Stock
50MG 198 In Stock
100MG 298 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Indisulam
  • Note
    Research use only, not for human use.
  • Brief Description
    Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines.
  • Description
    Indisulam (E7070) is potent, sulfonamide, cell-cycle inhibitor that possesses antiproliferative activities, causes decrease in the S phase fraction along with G1 and/or G2 accumulation in various cancer cell lines; causes blockade in the G1/S transition through inhibition of the activation of both cyclin-dependent kinase 2 and cyclin E, shows activity in multiple tumor types, most prominently in colon and lung cancer.Breast Cancer Phase 2 Discontinued
  • Synonyms
    E 7070;E7070
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    carbonicanhydrase;CDK
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    165668-41-7
  • Formula Weight
    385.85
  • Molecular Formula
    C14H12ClN3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 20mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
  • SMILES
    O=S(C1=CC=C(S(=O)(N)=O)C=C1)(NC2=CC=CC3=C2NC=C3Cl)=O
  • Chemical Name
    N-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. van Kesteren C, et al. Br J Clin Pharmacol. 2002 Nov;54(5):463-71.
2. Owa T, et al. J Med Chem. 2002 Oct 24;45(22):4913-22.
3. Ozawa Y, et al. Eur J Cancer. 2001 Nov;37(17):2275-82.
4. Tsukahara K, et al. Mol Pharmacol. 2001 Dec;60(6):1254-9.
molnova catalog
related products
  • CYC065

    CYC065 is a derivative of seliciclib and second generation CDK inhibitor that is mainly active on CDK2/5/9.

  • 8-OH-Dpat

    8-OH-Dpat is a serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.

  • Ibulocydine

    Ibulocydine is the prodrug of CDK inhibitor BMK-Y101, inhibits CDK7 and CDK9 with IC50 of 530 nM and 85 nM in kinase assays, respectively.